Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Mental Health Congress highlights Article Opportunities to improve global mental health Migraine Satellite symposium Article Getting a head start on Migraine Prevention Depression Article What do patients want and expect from their treatment for depression? Mental Health Article Meeting migraine’s mental health challenge